Biochemical Markers of Bone Turnover and Risk of Incident Diabetes in Older Women: The Cardiovascular Health Study

To investigate the relationship of osteocalcin (OC), a marker of bone formation, and C-terminal cross-linked telopeptide of type I collagen (CTX), a marker of bone resorption, with incident diabetes in older women. The analysis included 1,455 female participants from the population-based Cardiovascu...

Full description

Saved in:
Bibliographic Details
Published inDiabetes care Vol. 41; no. 9; pp. 1901 - 1908
Main Authors Massera, Daniele, Biggs, Mary L., Walker, Marcella D., Mukamal, Kenneth J., Ix, Joachim H., Djousse, Luc, Valderrábano, Rodrigo J., Siscovick, David S., Tracy, Russell P., Xue, Xiaonan, Kizer, Jorge R.
Format Journal Article
LanguageEnglish
Published United States American Diabetes Association 01.09.2018
Subjects
Online AccessGet full text
ISSN0149-5992
1935-5548
1935-5548
DOI10.2337/dc18-0849

Cover

Abstract To investigate the relationship of osteocalcin (OC), a marker of bone formation, and C-terminal cross-linked telopeptide of type I collagen (CTX), a marker of bone resorption, with incident diabetes in older women. The analysis included 1,455 female participants from the population-based Cardiovascular Health Study (CHS) (mean [SD] age 74.6 [5.0] years). The cross-sectional association of serum total OC and CTX levels with insulin resistance (HOMA-IR) was examined using multiple linear regression. The longitudinal association of both markers with incident diabetes, defined by follow-up glucose measurements, medications, and ICD-9 codes, was examined using multivariable Cox proportional hazards models. OC and CTX were strongly correlated ( = 0.80). In cross-sectional analyses, significant or near-significant inverse associations with HOMA-IR were observed for continuous levels of OC (β = -0.12 per SD increment; = 0.004) and CTX (β = -0.08 per SD; = 0.051) after full adjustment for demographic, lifestyle, and clinical covariates. During a median follow-up of 11.5 years, 196 cases of incident diabetes occurred. After full adjustment, both biomarkers exhibited inverse associations with incident diabetes (OC: hazard ratio 0.85 per SD [95% CI 0.71-1.02; = 0.075]; CTX: 0.82 per SD [0.69-0.98; = 0.031]), associations that were comparable in magnitude and approached or achieved statistical significance. In late postmenopausal women, lower OC and CTX levels were associated with similarly increased risks of insulin resistance at baseline and incident diabetes over long-term follow-up. Further research to delineate the mechanisms linking abnormal bone homeostasis and energy metabolism could uncover new approaches for the prevention of these age-related disorders.
AbstractList OBJECTIVE To investigate the relationship of osteocalcin (OC), a marker of bone formation, and C-terminal cross-linked telopeptide of type I collagen (CTX), a marker of bone resorption, with incident diabetes in older women. RESEARCH DESIGN AND METHODS The analysis included 1,455 female participants from the population-based Cardiovascular Health Study (CHS) (mean [SD] age 74.6 [5.0] years). The cross-sectional association of serum total OC and CTX levels with insulin resistance (HOMA-IR) was examined using multiple linear regression. The longitudinal association of both markers with incident diabetes, defined by follow-up glucose measurements, medications, and ICD-9 codes, was examined using multivariable Cox proportional hazards models. RESULTS OC and CTX were strongly correlated (r = 0.80). In cross-sectional analyses, significant or near-significant inverse associations with HOMA-IR were observed for continuous levels of OC (β = −0.12 per SD increment; P = 0.004) and CTX (β = −0.08 per SD; P = 0.051) after full adjustment for demographic, lifestyle, and clinical covariates. During a median follow-up of 11.5 years, 196 cases of incident diabetes occurred. After full adjustment, both biomarkers exhibited inverse associations with incident diabetes (OC: hazard ratio 0.85 per SD [95% CI 0.71–1.02; P = 0.075]; CTX: 0.82 per SD [0.69–0.98; P = 0.031]), associations that were comparable in magnitude and approached or achieved statistical significance. CONCLUSIONS In late postmenopausal women, lower OC and CTX levels were associated with similarly increased risks of insulin resistance at baseline and incident diabetes over long-term follow-up. Further research to delineate the mechanisms linking abnormal bone homeostasis and energy metabolism could uncover new approaches for the prevention of these age-related disorders.
To investigate the relationship of osteocalcin (OC), a marker of bone formation, and C-terminal cross-linked telopeptide of type I collagen (CTX), a marker of bone resorption, with incident diabetes in older women. The analysis included 1,455 female participants from the population-based Cardiovascular Health Study (CHS) (mean [SD] age 74.6 [5.0] years). The cross-sectional association of serum total OC and CTX levels with insulin resistance (HOMA-IR) was examined using multiple linear regression. The longitudinal association of both markers with incident diabetes, defined by follow-up glucose measurements, medications, and ICD-9 codes, was examined using multivariable Cox proportional hazards models. OC and CTX were strongly correlated ( = 0.80). In cross-sectional analyses, significant or near-significant inverse associations with HOMA-IR were observed for continuous levels of OC (β = -0.12 per SD increment; = 0.004) and CTX (β = -0.08 per SD; = 0.051) after full adjustment for demographic, lifestyle, and clinical covariates. During a median follow-up of 11.5 years, 196 cases of incident diabetes occurred. After full adjustment, both biomarkers exhibited inverse associations with incident diabetes (OC: hazard ratio 0.85 per SD [95% CI 0.71-1.02; = 0.075]; CTX: 0.82 per SD [0.69-0.98; = 0.031]), associations that were comparable in magnitude and approached or achieved statistical significance. In late postmenopausal women, lower OC and CTX levels were associated with similarly increased risks of insulin resistance at baseline and incident diabetes over long-term follow-up. Further research to delineate the mechanisms linking abnormal bone homeostasis and energy metabolism could uncover new approaches for the prevention of these age-related disorders.
To investigate the relationship of osteocalcin (OC), a marker of bone formation, and C-terminal cross-linked telopeptide of type I collagen (CTX), a marker of bone resorption, with incident diabetes in older women.OBJECTIVETo investigate the relationship of osteocalcin (OC), a marker of bone formation, and C-terminal cross-linked telopeptide of type I collagen (CTX), a marker of bone resorption, with incident diabetes in older women.The analysis included 1,455 female participants from the population-based Cardiovascular Health Study (CHS) (mean [SD] age 74.6 [5.0] years). The cross-sectional association of serum total OC and CTX levels with insulin resistance (HOMA-IR) was examined using multiple linear regression. The longitudinal association of both markers with incident diabetes, defined by follow-up glucose measurements, medications, and ICD-9 codes, was examined using multivariable Cox proportional hazards models.RESEARCH DESIGN AND METHODSThe analysis included 1,455 female participants from the population-based Cardiovascular Health Study (CHS) (mean [SD] age 74.6 [5.0] years). The cross-sectional association of serum total OC and CTX levels with insulin resistance (HOMA-IR) was examined using multiple linear regression. The longitudinal association of both markers with incident diabetes, defined by follow-up glucose measurements, medications, and ICD-9 codes, was examined using multivariable Cox proportional hazards models.OC and CTX were strongly correlated (r = 0.80). In cross-sectional analyses, significant or near-significant inverse associations with HOMA-IR were observed for continuous levels of OC (β = -0.12 per SD increment; P = 0.004) and CTX (β = -0.08 per SD; P = 0.051) after full adjustment for demographic, lifestyle, and clinical covariates. During a median follow-up of 11.5 years, 196 cases of incident diabetes occurred. After full adjustment, both biomarkers exhibited inverse associations with incident diabetes (OC: hazard ratio 0.85 per SD [95% CI 0.71-1.02; P = 0.075]; CTX: 0.82 per SD [0.69-0.98; P = 0.031]), associations that were comparable in magnitude and approached or achieved statistical significance.RESULTSOC and CTX were strongly correlated (r = 0.80). In cross-sectional analyses, significant or near-significant inverse associations with HOMA-IR were observed for continuous levels of OC (β = -0.12 per SD increment; P = 0.004) and CTX (β = -0.08 per SD; P = 0.051) after full adjustment for demographic, lifestyle, and clinical covariates. During a median follow-up of 11.5 years, 196 cases of incident diabetes occurred. After full adjustment, both biomarkers exhibited inverse associations with incident diabetes (OC: hazard ratio 0.85 per SD [95% CI 0.71-1.02; P = 0.075]; CTX: 0.82 per SD [0.69-0.98; P = 0.031]), associations that were comparable in magnitude and approached or achieved statistical significance.In late postmenopausal women, lower OC and CTX levels were associated with similarly increased risks of insulin resistance at baseline and incident diabetes over long-term follow-up. Further research to delineate the mechanisms linking abnormal bone homeostasis and energy metabolism could uncover new approaches for the prevention of these age-related disorders.CONCLUSIONSIn late postmenopausal women, lower OC and CTX levels were associated with similarly increased risks of insulin resistance at baseline and incident diabetes over long-term follow-up. Further research to delineate the mechanisms linking abnormal bone homeostasis and energy metabolism could uncover new approaches for the prevention of these age-related disorders.
Author Biggs, Mary L.
Djousse, Luc
Siscovick, David S.
Xue, Xiaonan
Walker, Marcella D.
Valderrábano, Rodrigo J.
Kizer, Jorge R.
Mukamal, Kenneth J.
Massera, Daniele
Tracy, Russell P.
Ix, Joachim H.
Author_xml – sequence: 1
  givenname: Daniele
  orcidid: 0000-0002-9499-6456
  surname: Massera
  fullname: Massera, Daniele
  organization: Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY
– sequence: 2
  givenname: Mary L.
  surname: Biggs
  fullname: Biggs, Mary L.
  organization: University of Washington, Seattle, WA
– sequence: 3
  givenname: Marcella D.
  surname: Walker
  fullname: Walker, Marcella D.
  organization: Columbia University Vagelos College of Physicians and Surgeons, New York, NY
– sequence: 4
  givenname: Kenneth J.
  surname: Mukamal
  fullname: Mukamal, Kenneth J.
  organization: Beth Israel Deaconess Medical Center, Boston, MA
– sequence: 5
  givenname: Joachim H.
  surname: Ix
  fullname: Ix, Joachim H.
  organization: University of California San Diego, San Diego, CA
– sequence: 6
  givenname: Luc
  surname: Djousse
  fullname: Djousse, Luc
  organization: Brigham and Women’s Hospital, Boston, MA
– sequence: 7
  givenname: Rodrigo J.
  surname: Valderrábano
  fullname: Valderrábano, Rodrigo J.
  organization: University of Miami, Miami, FL
– sequence: 8
  givenname: David S.
  surname: Siscovick
  fullname: Siscovick, David S.
  organization: The New York Academy of Medicine, New York, NY
– sequence: 9
  givenname: Russell P.
  surname: Tracy
  fullname: Tracy, Russell P.
  organization: University of Vermont, Burlington, VT
– sequence: 10
  givenname: Xiaonan
  surname: Xue
  fullname: Xue, Xiaonan
  organization: Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY
– sequence: 11
  givenname: Jorge R.
  orcidid: 0000-0001-9936-7803
  surname: Kizer
  fullname: Kizer, Jorge R.
  organization: Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30002202$$D View this record in MEDLINE/PubMed
BookMark eNptkV1rFDEUhoNU7Hb1wj8gAW_0Ymw-dxIvBLt-tFAp6IqXIZuccdPOJDWZWei_N0Nr0eJVDjnPefOevEfoIKYICD2n5A3jvD32jqqGKKEfoQXVXDZSCnWAFoQK3Uit2SE6KuWSECKEUk_QIa8lY4QtUD4Jye1gCM72-IvNV5ALTh0-qS_gzZRj2kPGNnr8NZSruXMWXfAQR_wh2C2MUHCI-KL3FfuRBohv8WYHeG2zD2lvi5t6m_Ep2H7c4W_j5G-eosed7Qs8uzuX6Punj5v1aXN-8fls_f68cWKlx0asvKAg6Ra44pZZQiWlzHfaSb4F0Wndss5RzThTHSjvhKVtvfXbFghRhC_Ru1vd62k7gHfVc7a9uc5hsPnGJBvMv50YduZn2psVJZLzWeDVnUBOvyYooxlCcdD3NkKaimGkJYy3SqiKvnyAXqb6eXU9wyiV7UrIKrlEL_52dG_lTxwVeH0LuJxKydDdI5SYOWozR23mqCt7_IB1YbRjSPMyof_PxG9u6qqq
CitedBy_id crossref_primary_10_1016_j_bone_2020_115230
crossref_primary_10_1186_s10020_024_01000_9
crossref_primary_10_3390_ijms20194873
crossref_primary_10_1016_j_phyplu_2023_100495
crossref_primary_10_1142_S2661341722300075
crossref_primary_10_1002_jbmr_4519
crossref_primary_10_1093_nutrit_nuab055
crossref_primary_10_1097_MCO_0000000000000541
crossref_primary_10_1111_1753_0407_13089
crossref_primary_10_3389_fimmu_2022_990457
crossref_primary_10_3390_surgeries5020033
crossref_primary_10_1016_j_heliyon_2024_e33435
crossref_primary_10_3389_fendo_2022_803624
crossref_primary_10_1007_s00198_019_05043_1
crossref_primary_10_1186_s13041_019_0444_5
crossref_primary_10_46483_deuhfed_927575
crossref_primary_10_1016_j_apsb_2024_03_033
crossref_primary_10_1007_s12018_023_09288_7
crossref_primary_10_3389_fendo_2021_554604
crossref_primary_10_1016_j_nantod_2023_101839
crossref_primary_10_3390_ijms23042376
crossref_primary_10_1186_s13098_022_00932_8
crossref_primary_10_1007_s00774_021_01301_7
crossref_primary_10_2337_dc21_2113
crossref_primary_10_1016_j_bone_2024_117238
crossref_primary_10_1038_s41598_023_46813_6
crossref_primary_10_1002_jbmr_4330
crossref_primary_10_1155_2023_3872126
Cites_doi 10.2337/dc11-1519
10.2337/db14-1611
10.1016/j.cell.2007.05.047
10.1016/j.rcl.2010.02.014
10.1016/j.cell.2010.06.002
10.1016/j.bone.2006.09.011
10.1016/j.metabol.2016.06.002
10.1016/j.molmet.2013.08.004
10.2337/diabetes.50.10.2384
10.1359/jbmr.061113
10.1016/1047-2797(91)90005-W
10.1371/journal.pone.0138693
10.1210/jc.2013-2472
10.1016/S0140-6736(16)00618-8
10.1016/j.cmet.2013.05.001
10.2337/db16-0053
10.1210/er.2009-0024
10.1002/jbmr.1865
10.1016/j.bone.2008.02.006
10.1016/1047-2797(94)00092-8
10.1016/j.cell.2010.06.003
10.1016/j.bone.2015.05.046
10.1007/s10654-015-0058-x
10.1093/clinchem/41.2.264
10.1111/j.1365-2265.2011.04215.x
10.1038/boneres.2017.20
10.1056/NEJMoa1114248
10.1093/aje/kwm106
10.1002/dmrr.1045
10.1007/BF00280883
10.1093/aje/kwv278
10.2337/dc11-2471
10.1210/jc.2016-3282
10.1007/s00223-016-0210-y
10.1007/s00774-017-0857-0
10.1073/pnas.73.5.1447
10.1210/jc.2014-3019
10.4049/jimmunol.145.10.3297
10.1359/jbmr.2000.15.7.1398
10.1016/1047-2797(94)00093-9
ContentType Journal Article
Copyright 2018 by the American Diabetes Association.
Copyright American Diabetes Association Sep 1, 2018
2018 by the American Diabetes Association. 2018
Copyright_xml – notice: 2018 by the American Diabetes Association.
– notice: Copyright American Diabetes Association Sep 1, 2018
– notice: 2018 by the American Diabetes Association. 2018
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
K9.
NAPCQ
7X8
5PM
DOI 10.2337/dc18-0849
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
MEDLINE - Academic
DatabaseTitleList ProQuest Health & Medical Complete (Alumni)
MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1935-5548
EndPage 1908
ExternalDocumentID PMC6105330
30002202
10_2337_dc18_0849
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NHLBI NIH HHS
  grantid: HHSN268201200036C
– fundername: NHLBI NIH HHS
  grantid: N01 HC085086
– fundername: NHLBI NIH HHS
  grantid: N01 HC085082
– fundername: NHLBI NIH HHS
  grantid: U01 HL130114
– fundername: NHLBI NIH HHS
  grantid: HHSN268200800007C
– fundername: NHLBI NIH HHS
  grantid: U01 HL080295
– fundername: NHLBI NIH HHS
  grantid: N01 HC055222
– fundername: NHLBI NIH HHS
  grantid: K24 HL135413
– fundername: NHLBI NIH HHS
  grantid: N01 HC085081
– fundername: NHLBI NIH HHS
  grantid: N01 HC085079
– fundername: ;
– fundername: ;
  grantid: HHSN268201200036C; HHSN268200800007C; HHSN268201800001C; N01-HC-55222; N01-HC-85079; N01-HC-85080; N01-HC-85081; N01-HC-85082; N01-HC-85083; N01-HC-85086; U01-HL-080295; U01-HL-130114
– fundername: ;
  grantid: Glorney-Raisbeck Fellowship Program; K24-HL-135413
– fundername: ;
  grantid: R01-AG-023629
GroupedDBID ---
-ET
..I
.XZ
08P
0R~
18M
29F
2WC
4.4
53G
5GY
5RE
5RS
5VS
6PF
8R4
8R5
AAFWJ
AAIKC
AAMNW
AAWTL
AAYEP
AAYXX
ABOCM
ABPPZ
ACGFO
ACGOD
ADBBV
AEGXH
AENEX
AERZD
AFOSN
AFRAH
AHMBA
AIAGR
ALIPV
ALMA_UNASSIGNED_HOLDINGS
BAWUL
BENPR
BTFSW
CITATION
CS3
DIK
DU5
E3Z
EBS
EDB
EJD
EMOBN
EX3
F5P
GX1
H13
HZ~
IAO
IEA
IHR
INH
INR
IOF
IPO
KQ8
L7B
M0K
M5~
O5R
O5S
O9-
OK1
OVD
P2P
PCD
Q2X
RHI
SV3
TDI
TEORI
TR2
TWZ
VVN
W8F
WH7
WOQ
WOW
YHG
YOC
~KM
.55
.GJ
3O-
41~
7RV
7X2
7X7
88E
88I
8AF
8AO
8C1
8F7
8FE
8FH
8FI
8FJ
8G5
AAKAS
AAQOH
AAQQT
AAYJJ
ABUWG
ADZCM
AFFNX
AFKRA
AI.
AN0
AQUVI
ATCPS
AZQEC
BCR
BCU
BEC
BHPHI
BKEYQ
BKNYI
BLC
BNQBC
BPHCQ
BVXVI
C1A
CCPQU
CGR
CUY
CVF
DWQXO
ECM
EIF
FYUFA
GNUQQ
GUQSH
HCIFZ
HMCUK
IAG
ITC
J5H
K9-
M0R
M0T
M1P
M2O
M2P
M2Q
N4W
NAPCQ
NPM
PEA
PHGZM
PHGZT
PJZUB
PPXIY
PQQKQ
PROAC
PSQYO
S0X
SJFOW
UKHRP
VH1
WHG
X7M
ZCG
ZGI
ZXP
K9.
7X8
5PM
ID FETCH-LOGICAL-c469t-46d41e51be383a2a015112df9c53be4f9972fc192328fe8dc4a17f99db7e00803
ISSN 0149-5992
1935-5548
IngestDate Thu Aug 21 14:10:38 EDT 2025
Fri Sep 05 10:38:57 EDT 2025
Mon Jun 30 17:04:37 EDT 2025
Mon Jul 21 06:03:21 EDT 2025
Tue Jul 01 04:11:55 EDT 2025
Thu Apr 24 22:58:12 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 9
Language English
License 2018 by the American Diabetes Association.
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c469t-46d41e51be383a2a015112df9c53be4f9972fc192328fe8dc4a17f99db7e00803
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-9499-6456
0000-0001-9936-7803
OpenAccessLink https://care.diabetesjournals.org/content/diacare/41/9/1901.full.pdf
PMID 30002202
PQID 2115764553
PQPubID 47715
PageCount 8
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_6105330
proquest_miscellaneous_2070237848
proquest_journals_2115764553
pubmed_primary_30002202
crossref_primary_10_2337_dc18_0849
crossref_citationtrail_10_2337_dc18_0849
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2018-09-01
PublicationDateYYYYMMDD 2018-09-01
PublicationDate_xml – month: 09
  year: 2018
  text: 2018-09-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Alexandria
PublicationTitle Diabetes care
PublicationTitleAlternate Diabetes Care
PublicationYear 2018
Publisher American Diabetes Association
Publisher_xml – name: American Diabetes Association
References Brutsaert (2022031303350202500_B20) 2016; 65
Donath (2022031303350202500_B6) 2013; 17
Psaty (2022031303350202500_B23) 1995; 5
Fried (2022031303350202500_B16) 1991; 1
Fulzele (2022031303350202500_B32) 2010; 142
Ngarmukos (2022031303350202500_B39) 2012; 77
Urano (2022031303350202500_B13) 2018; 36
Alikhani (2022031303350202500_B36) 2007; 40
Zoch (2022031303350202500_B9) 2016; 82
Hwang (2022031303350202500_B27) 2009; 25
NCD Risk Factor Collaboration (NCD-RisC) (2022031303350202500_B1) 2016; 387
Bonnet (2022031303350202500_B8) 2017; 100
Díaz-López (2022031303350202500_B41) 2013; 98
Cushman (2022031303350202500_B18) 1995; 41
Burge (2022031303350202500_B2) 2007; 22
Tonks (2022031303350202500_B34) 2017; 102
Karas (2022031303350202500_B24) 2016; 183
Rogers (2022031303350202500_B30) 2000; 15
Yeap (2022031303350202500_B31) 2015; 100
Ives (2022031303350202500_B17) 1995; 5
Ferron (2022031303350202500_B33) 2010; 142
Liu (2022031303350202500_B15) 2017; 5
Inker (2022031303350202500_B22) 2012; 367
Janghorbani (2022031303350202500_B4) 2007; 166
Hwang (2022031303350202500_B14) 2012; 35
Manolagas (2022031303350202500_B25) 2010; 31
Zwakenberg (2022031303350202500_B40) 2015; 10
Schwartz (2022031303350202500_B37) 2013; 28
Price (2022031303350202500_B29) 1976; 73
Ishimi (2022031303350202500_B5) 1990; 145
Lee (2022031303350202500_B10) 2007; 130
Kizer (2022031303350202500_B19) 2012; 35
Clarke (2022031303350202500_B7) 2010; 48
Wittrant (2022031303350202500_B35) 2008; 42
Matthews (2022031303350202500_B21) 1985; 28
Khan (2022031303350202500_B3) 2015; 64
Gundberg (2022031303350202500_B38) 1998; 83
Barzilay (2022031303350202500_B26) 2001; 50
Lacombe (2022031303350202500_B28) 2013; 2
Kunutsor (2022031303350202500_B12) 2015; 30
Liu (2022031303350202500_B11) 2016; 65
References_xml – volume: 35
  start-page: 415
  year: 2012
  ident: 2022031303350202500_B19
  article-title: Total and high-molecular-weight adiponectin and risk of incident diabetes in older people
  publication-title: Diabetes Care
  doi: 10.2337/dc11-1519
– volume: 64
  start-page: 2609
  year: 2015
  ident: 2022031303350202500_B3
  article-title: Pathophysiological mechanism of bone loss in type 2 diabetes involves inverse regulation of osteoblast function by PGC-1α and skeletal muscle atrogenes: AdipoR1 as a potential target for reversing diabetes-induced osteopenia
  publication-title: Diabetes
  doi: 10.2337/db14-1611
– volume: 130
  start-page: 456
  year: 2007
  ident: 2022031303350202500_B10
  article-title: Endocrine regulation of energy metabolism by the skeleton
  publication-title: Cell
  doi: 10.1016/j.cell.2007.05.047
– volume: 48
  start-page: 483
  year: 2010
  ident: 2022031303350202500_B7
  article-title: Physiology of bone loss
  publication-title: Radiol Clin North Am
  doi: 10.1016/j.rcl.2010.02.014
– volume: 83
  start-page: 3258
  year: 1998
  ident: 2022031303350202500_B38
  article-title: Vitamin K status and bone health: an analysis of methods for determination of undercarboxylated osteocalcin
  publication-title: J Clin Endocrinol Metab
– volume: 142
  start-page: 309
  year: 2010
  ident: 2022031303350202500_B32
  article-title: Insulin receptor signaling in osteoblasts regulates postnatal bone acquisition and body composition
  publication-title: Cell
  doi: 10.1016/j.cell.2010.06.002
– volume: 40
  start-page: 345
  year: 2007
  ident: 2022031303350202500_B36
  article-title: Advanced glycation end products stimulate osteoblast apoptosis via the MAP kinase and cytosolic apoptotic pathways
  publication-title: Bone
  doi: 10.1016/j.bone.2006.09.011
– volume: 65
  start-page: 1489
  year: 2016
  ident: 2022031303350202500_B20
  article-title: Longitudinal assessment of N-terminal pro-B-type natriuretic peptide and risk of diabetes in older adults: the Cardiovascular Health Study
  publication-title: Metabolism
  doi: 10.1016/j.metabol.2016.06.002
– volume: 2
  start-page: 498
  year: 2013
  ident: 2022031303350202500_B28
  article-title: In vivo analysis of the contribution of bone resorption to the control of glucose metabolism in mice
  publication-title: Mol Metab
  doi: 10.1016/j.molmet.2013.08.004
– volume: 50
  start-page: 2384
  year: 2001
  ident: 2022031303350202500_B26
  article-title: The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study
  publication-title: Diabetes
  doi: 10.2337/diabetes.50.10.2384
– volume: 22
  start-page: 465
  year: 2007
  ident: 2022031303350202500_B2
  article-title: Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025
  publication-title: J Bone Miner Res
  doi: 10.1359/jbmr.061113
– volume: 1
  start-page: 263
  year: 1991
  ident: 2022031303350202500_B16
  article-title: The Cardiovascular Health Study: design and rationale
  publication-title: Ann Epidemiol
  doi: 10.1016/1047-2797(91)90005-W
– volume: 10
  start-page: e0138693
  year: 2015
  ident: 2022031303350202500_B40
  article-title: Osteocalcin is not associated with the risk of type 2 diabetes: findings from the EPIC-NL study
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0138693
– volume: 98
  start-page: 4524
  year: 2013
  ident: 2022031303350202500_B41
  article-title: Reduced serum concentrations of carboxylated and undercarboxylated osteocalcin are associated with risk of developing type 2 diabetes mellitus in a high cardiovascular risk population: a nested case-control study
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2013-2472
– volume: 387
  start-page: 1513
  year: 2016
  ident: 2022031303350202500_B1
  article-title: Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants
  publication-title: Lancet
  doi: 10.1016/S0140-6736(16)00618-8
– volume: 17
  start-page: 860
  year: 2013
  ident: 2022031303350202500_B6
  article-title: Inflammation in obesity and diabetes: islet dysfunction and therapeutic opportunity
  publication-title: Cell Metab
  doi: 10.1016/j.cmet.2013.05.001
– volume: 65
  start-page: 3225
  year: 2016
  ident: 2022031303350202500_B11
  article-title: Regulation of glucose handling by the skeleton: insights from mouse and human studies
  publication-title: Diabetes
  doi: 10.2337/db16-0053
– volume: 31
  start-page: 266
  year: 2010
  ident: 2022031303350202500_B25
  article-title: From estrogen-centric to aging and oxidative stress: a revised perspective of the pathogenesis of osteoporosis
  publication-title: Endocr Rev
  doi: 10.1210/er.2009-0024
– volume: 28
  start-page: 1348
  year: 2013
  ident: 2022031303350202500_B37
  article-title: Effects of antiresorptive therapies on glucose metabolism: results from the FIT, HORIZON-PFT, and FREEDOM trials
  publication-title: J Bone Miner Res
  doi: 10.1002/jbmr.1865
– volume: 42
  start-page: 1122
  year: 2008
  ident: 2022031303350202500_B35
  article-title: High d(+)glucose concentration inhibits RANKL-induced osteoclastogenesis
  publication-title: Bone
  doi: 10.1016/j.bone.2008.02.006
– volume: 5
  start-page: 270
  year: 1995
  ident: 2022031303350202500_B23
  article-title: Methods of assessing prevalent cardiovascular disease in the Cardiovascular Health Study
  publication-title: Ann Epidemiol
  doi: 10.1016/1047-2797(94)00092-8
– volume: 142
  start-page: 296
  year: 2010
  ident: 2022031303350202500_B33
  article-title: Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism
  publication-title: Cell
  doi: 10.1016/j.cell.2010.06.003
– volume: 82
  start-page: 42
  year: 2016
  ident: 2022031303350202500_B9
  article-title: New insights into the biology of osteocalcin
  publication-title: Bone
  doi: 10.1016/j.bone.2015.05.046
– volume: 30
  start-page: 599
  year: 2015
  ident: 2022031303350202500_B12
  article-title: Association of serum total osteocalcin with type 2 diabetes and intermediate metabolic phenotypes: systematic review and meta-analysis of observational evidence
  publication-title: Eur J Epidemiol
  doi: 10.1007/s10654-015-0058-x
– volume: 41
  start-page: 264
  year: 1995
  ident: 2022031303350202500_B18
  article-title: Laboratory methods and quality assurance in the Cardiovascular Health Study
  publication-title: Clin Chem
  doi: 10.1093/clinchem/41.2.264
– volume: 77
  start-page: 42
  year: 2012
  ident: 2022031303350202500_B39
  article-title: A reduced serum level of total osteocalcin in men predicts the development of diabetes in a long-term follow-up cohort
  publication-title: Clin Endocrinol (Oxf)
  doi: 10.1111/j.1365-2265.2011.04215.x
– volume: 5
  start-page: 17020
  year: 2017
  ident: 2022031303350202500_B15
  article-title: The association between the baseline bone resorption marker CTX and incident dysglycemia after 4 years
  publication-title: Bone Res
  doi: 10.1038/boneres.2017.20
– volume: 367
  start-page: 20
  year: 2012
  ident: 2022031303350202500_B22
  article-title: Estimating glomerular filtration rate from serum creatinine and cystatin C
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1114248
– volume: 166
  start-page: 495
  year: 2007
  ident: 2022031303350202500_B4
  article-title: Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture
  publication-title: Am J Epidemiol
  doi: 10.1093/aje/kwm106
– volume: 25
  start-page: 768
  year: 2009
  ident: 2022031303350202500_B27
  article-title: The uncarboxylated form of osteocalcin is associated with improved glucose tolerance and enhanced beta-cell function in middle-aged male subjects
  publication-title: Diabetes Metab Res Rev
  doi: 10.1002/dmrr.1045
– volume: 28
  start-page: 412
  year: 1985
  ident: 2022031303350202500_B21
  article-title: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man
  publication-title: Diabetologia
  doi: 10.1007/BF00280883
– volume: 183
  start-page: 998
  year: 2016
  ident: 2022031303350202500_B24
  article-title: Measures of body size and composition and risk of incident atrial fibrillation in older people: the Cardiovascular Health Study
  publication-title: Am J Epidemiol
  doi: 10.1093/aje/kwv278
– volume: 35
  start-page: 1919
  year: 2012
  ident: 2022031303350202500_B14
  article-title: Circulating osteocalcin level is not associated with incident type 2 diabetes in middle-aged male subjects: mean 8.4-year retrospective follow-up study
  publication-title: Diabetes Care
  doi: 10.2337/dc11-2471
– volume: 102
  start-page: 1112
  year: 2017
  ident: 2022031303350202500_B34
  article-title: Bone turnover is suppressed in insulin resistance, independent of adiposity
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2016-3282
– volume: 100
  start-page: 174
  year: 2017
  ident: 2022031303350202500_B8
  article-title: Bone-derived factors: a new gateway to regulate glycemia
  publication-title: Calcif Tissue Int
  doi: 10.1007/s00223-016-0210-y
– volume: 36
  start-page: 470
  year: 2018
  ident: 2022031303350202500_B13
  article-title: Low serum osteocalcin concentration is associated with incident type 2 diabetes mellitus in Japanese women
  publication-title: J Bone Miner Metab
  doi: 10.1007/s00774-017-0857-0
– volume: 73
  start-page: 1447
  year: 1976
  ident: 2022031303350202500_B29
  article-title: Characterization of a gamma-carboxyglutamic acid-containing protein from bone
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.73.5.1447
– volume: 100
  start-page: 63
  year: 2015
  ident: 2022031303350202500_B31
  article-title: Higher serum undercarboxylated osteocalcin and other bone turnover markers are associated with reduced diabetes risk and lower estradiol concentrations in older men
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2014-3019
– volume: 145
  start-page: 3297
  year: 1990
  ident: 2022031303350202500_B5
  article-title: IL-6 is produced by osteoblasts and induces bone resorption
  publication-title: J Immunol
  doi: 10.4049/jimmunol.145.10.3297
– volume: 15
  start-page: 1398
  year: 2000
  ident: 2022031303350202500_B30
  article-title: Biochemical markers as predictors of rates of bone loss after menopause
  publication-title: J Bone Miner Res
  doi: 10.1359/jbmr.2000.15.7.1398
– volume: 5
  start-page: 278
  year: 1995
  ident: 2022031303350202500_B17
  article-title: Surveillance and ascertainment of cardiovascular events: the Cardiovascular Health Study
  publication-title: Ann Epidemiol
  doi: 10.1016/1047-2797(94)00093-9
SSID ssj0004488
Score 2.443127
Snippet To investigate the relationship of osteocalcin (OC), a marker of bone formation, and C-terminal cross-linked telopeptide of type I collagen (CTX), a marker of...
OBJECTIVE To investigate the relationship of osteocalcin (OC), a marker of bone formation, and C-terminal cross-linked telopeptide of type I collagen (CTX), a...
SourceID pubmedcentral
proquest
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 1901
SubjectTerms Age
Aged
Aged, 80 and over
Biochemical markers
Biocompatibility
Biomarkers
Biomarkers - analysis
Biomarkers - blood
Biomedical materials
Bone and Bones - metabolism
Bone growth
Bone Remodeling - physiology
Bone resorption
Bone Resorption - blood
Bone Resorption - epidemiology
Bone turnover
Cardiovascular disease
Cardiovascular System - physiopathology
Collagen (type I)
Collagen Type I - blood
Cross-Sectional Studies
Crosslinking
Demographics
Diabetes
Diabetes mellitus
Diabetes Mellitus - blood
Diabetes Mellitus - epidemiology
Energy metabolism
Epidemiology/Health Services Research
Female
Hazards
Health risks
Homeostasis
Humans
Incidence
Insulin
Metabolism
Older people
Osteocalcin
Osteocalcin - blood
Osteogenesis
Osteoporosis
Population (statistical)
Population studies
Post-menopause
Regression analysis
Research design
Risk Factors
Statistical analysis
Statistical models
Womens health
Title Biochemical Markers of Bone Turnover and Risk of Incident Diabetes in Older Women: The Cardiovascular Health Study
URI https://www.ncbi.nlm.nih.gov/pubmed/30002202
https://www.proquest.com/docview/2115764553
https://www.proquest.com/docview/2070237848
https://pubmed.ncbi.nlm.nih.gov/PMC6105330
Volume 41
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Pb9MwFLbKkKZdEL_JGMggDkhRShPbTcKNdaAxKCCxSbtFjpOIii2dRnrhr-NP4z3bcdytB9glahM3Tvq-PH923vseIa9SKaWYVDxCLfIIR4yozCcKsFxKJkpRMV3rcP5lenjCj07F6Wj0x4taWnXlWP3emFdyE6vCPrArZsn-h2XdSWEHfAb7whYsDNt_svH-AutdmYR_TLrBZFwgf_tLYI5Ywh7DM00Gog0gB2-ARUS78KBfcl204Vcs1B3qUpZ9DMZsPUrV5ip9d1K0ls26s2D82LC2jW_4pZe_fm0hfo6hep_H3mK-je2YS_0mQYYH4wEJP-W59HOIwqOxv1YRZy4Yq_PSA8Bvucu7isF-kTOPRG5q5I1r45hzJiKgPpnvuY1klkVo7rlhZDnekA5fs03DRcK04ECl8EozI53qwebiXOOGaZGgSTKMmC6O8dt8BvQTA3RvkdtJCuwNafnHT0NmLteVT90dGW0r7PeN63WHbPddrJOjazOeq4G7HhM6vkvu2CkMfWfweI-M6vY-2Z7bII0H5NKDJbWwpMuGIixpD0sKsKQISzzSw5L2FqOLlmpYUg3LtxRASddBSQ0oqQblQ3Ly4f3x7DCypT0ixad5F_FpxeNaxGXNMiYTCaQUiH_V5EqwsuYNpnM3CmcfSdbUWaW4jFPYi2LgOMlhj8hWC1f9hNAkZjXWp1dNBq1UDgyU16JSE4Vil5wH5HX_nxbK6t5j-ZWzAua_aIkCLVGgJQLy0jW9MGIvmxrt9YYprC_4VSSoWTXlQrCAvHCHwVPrh6atlytoA6NrwtKMZwF5bOzoeukBEJB0zcKuAarArx9pFz-0GrwF4O6Nf_mU7AzP6h7Z6i5X9TNg2l35XIP5L_Oc1Q8
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Biochemical+Markers+of+Bone+Turnover+and+Risk+of+Incident+Diabetes+in+Older+Women%3A+The+Cardiovascular+Health+Study&rft.jtitle=Diabetes+care&rft.au=Massera%2C+Daniele&rft.au=Biggs%2C+Mary+L.&rft.au=Walker%2C+Marcella+D.&rft.au=Mukamal%2C+Kenneth+J.&rft.date=2018-09-01&rft.pub=American+Diabetes+Association&rft.issn=0149-5992&rft.eissn=1935-5548&rft.volume=41&rft.issue=9&rft.spage=1901&rft.epage=1908&rft_id=info:doi/10.2337%2Fdc18-0849&rft_id=info%3Apmid%2F30002202&rft.externalDocID=PMC6105330
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0149-5992&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0149-5992&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0149-5992&client=summon